Transmission-Based Precautions: Contact, Droplet, and Airborne

Transmission-based precautions are the additional infection-control measures — beyond routine standard precautions — used when a patient’s known or suspected infection can spread by a route that standard precautions alone do not fully interrupt. CDC’s 2007 Guideline for Isolation Precautions (HICPAC), last updated in September 2024, organizes them into three categories: Contact, Droplet, and Airborne precautions. Search interest in this topic is usually split across “droplet precautions,” “contact precautions,” “transmission-based precautions,” and “isolation precautions” — this page covers all four as one decision, because in practice a clinician or infection preventionist is answering one question: given this patient’s suspected diagnosis, which category (or combination) applies, what PPE and room placement does it require, and when can it be discontinued.

Page checked against the CDC/HICPAC Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings (2007), as maintained with periodic updates (last update noted September 2024), retrieved via the RestoredCDC.org archive in August 2026 after cdc.gov blocked automated retrieval. This guide covers precaution category, PPE, and room placement. It does not cover airborne infection isolation room engineering specifications (negative pressure, air changes per hour, HEPA filtration) — see our separate Airborne Infection Isolation Room (AIIR) guide for that.

Standard Precautions: The Baseline for Every Patient

Transmission-based precautions are always used in addition to standard precautions, never instead of them. Standard precautions — hand hygiene, use of PPE based on anticipated exposure, safe injection practices, respiratory hygiene/cough etiquette, and safe handling of contaminated equipment and surfaces — apply to every patient, every time, regardless of suspected infection status. The three transmission-based categories exist because some infectious agents spread by a route that standard precautions do not fully interrupt on their own.

Contact Precautions

Contact Precautions prevent transmission by direct or indirect contact with the patient or the patient’s environment — relevant for organisms like MRSA, VRE, C. difficile, and other multidrug-resistant organisms (MDROs), as well as conditions producing heavy wound drainage, fecal incontinence, or other discharges that raise the risk of environmental contamination. In nursing homes specifically, CDC recommends a less restrictive alternative for most MDRO colonization — Enhanced Barrier Precautions, which apply gown and gloves to eight named high-contact resident care activities without room restriction, private-room placement, or dedicated equipment. Contact Precautions remain the correct choice in that setting only for secretions or excretions that cannot be covered or contained, during an outbreak investigation, where the shape of the epidemic curve is what distinguishes a common source from person-to-person spread, or for a separately indicated condition such as C. difficile.

• PPE: gown and gloves for all interactions that may involve contact with the patient or potentially contaminated surfaces in the room, donned on room entry and removed before exiting — see the isolation PPE donning and doffing sequence for the removal order and the trained-observer check that verifies it.
• Room placement: a single-patient room is preferred. When one is not available, infection control personnel should be consulted on cohorting or other placement options; in multi-bed rooms, at least 3 feet of spatial separation between beds is advised.
• Duration: generally undefined for MDRO colonization/infection — CDC notes that for some organisms (MRSA, VRE) colonization can persist for months, and that facilities may either treat carriers as permanently colonized or use a defined interval free of hospitalization, antimicrobial therapy, and invasive devices before re-culturing to document clearance. For infections with a defined course, precautions run for the duration of illness or shedding as specified in the guideline’s infection-specific reference table.

Droplet Precautions

Droplet Precautions prevent transmission through close respiratory or mucous-membrane contact with respiratory secretions — for agents such as B. pertussis, influenza virus, adenovirus, rhinovirus, N. meningitidis, and group A streptococcus (for the first 24 hours of effective antimicrobial therapy). Because these pathogens do not remain infectious over long distances, special air handling is not required.

• PPE: a mask (not a respirator) for close contact with the patient, generally donned on room entry.
• Room placement: a single-patient room is preferred; when unavailable, use spatial separation of at least 3 feet and draw the curtain between beds in a multi-bed room.
• Patient transport: the patient should wear a mask if tolerated and follow respiratory hygiene/cough etiquette when transported outside the room.
• Duration: generally for the course of the illness or as specified for the specific organism (e.g., group A strep only requires 24 hours of effective therapy before discontinuation, in the absence of other complicating factors).

Airborne Precautions

Airborne Precautions prevent transmission of agents that remain infectious over long distances when suspended in air — measles (rubeola), varicella (chickenpox), and M. tuberculosis are the canonical examples.

• PPE: a fit-tested NIOSH-certified N95 or higher-level respirator (not a surgical mask), donned before room entry; the specific respiratory protection depends on the disease per the guideline’s reference tables, and a facility respiratory-protection program (education, fit-testing, user seal checks) is required wherever airborne infection isolation rooms are in use.
• Room placement: the preferred placement is an airborne infection isolation room (AIIR) — a single-patient room with special air handling and ventilation meeting AIA/FGI standards (monitored negative pressure, defined air-exchange rates, and exhaust either directly outside or HEPA-filtered before recirculation). See our AIIR guide for the engineering specifications and monitoring requirements in full. Where an AIIR is not available (e.g., a physician’s office), CDC describes masking the patient, using a private room with the door closed, and using respirators or masks for staff as an interim measure until the patient can be transferred or sent home as medically appropriate.
• Staffing: non-immune healthcare workers should not, whenever possible, care for patients with vaccine-preventable airborne diseases such as measles or chickenpox.
• Duration: disease-specific — determined by known shedding patterns, and for some diseases (notably M. tuberculosis) also governed by state law and facility policy rather than the CDC guideline alone.

Using More Than One Category at Once

Some infections have more than one transmission route and require combined precautions. CDC’s own guideline cites SARS as an example where Contact, Droplet, and (per some jurisdictions’ experience) Airborne precautions were used together. When more than one category applies, the PPE and room-placement requirements of each apply cumulatively, not as alternatives.

Deciding Empirically, Before a Diagnosis Is Confirmed

Laboratory confirmation for many infections takes two or more days. The guideline addresses this directly: certain clinical syndromes and presentations carry a high enough risk that empiric transmission-based precautions should start at the time of presentation — based on signs, symptoms, and likely pathogens — rather than waiting for a confirmed result. The guideline’s Table 2 (Clinical Syndromes or Conditions Warranting Empiric Transmission-Based Precautions) is the structured reference for this; infection prevention programs are explicitly encouraged to adapt it to local conditions and organism prevalence, so a facility’s actual empiric-precautions policy should be checked against its own infection control program rather than assumed from the base guideline alone.

When to Discontinue Precautions

The guideline frames discontinuation around persistence of transmission risk rather than a single universal clock. In general terms:

• Most infections have precautions tied to the known natural history of shedding for that pathogen and its treatment — this is disease-specific, not a fixed number of days across the board.
• Some diseases (for example, diphtheria or RSV) remain under precautions until culture or antigen-detection testing documents eradication of the pathogen, and, for RSV, until symptomatic disease has resolved.
• In immunocompromised patients, viral shedding can persist for weeks to months, which may extend the duration of Contact or Droplet precautions well beyond what would apply to an immunocompetent patient with the same diagnosis.
• MDRO colonization duration is, per CDC, genuinely undefined in the general case — see the Contact Precautions section above.

Because discontinuation criteria are disease-specific, the operational reference is the guideline’s Appendix A (“Type and Duration of Precautions Recommended for Selected Infections and Conditions”) rather than a general rule — an infection preventionist or antimicrobial stewardship program (see our Antimicrobial Stewardship Program guide) will typically maintain a facility-specific quick-reference version of this table. Discontinuation is also the trigger for the environmental side of the same decision: when the patient is discharged or transferred, the precaution category that applied to them determines the PPE, the disinfectant and the room hold time for the terminal clean of the vacated room, which is why the precaution sign should not be removed before environmental services has been told what it is walking into.

Ambulatory and Home Care Settings

The guideline notes that transmission-based precautions generally apply across all healthcare settings but require adaptation outside acute inpatient care. Home care settings do not have AIIRs available; family members already exposed to a disease such as varicella or tuberculosis would not necessarily use masks or respiratory protection themselves, even though a visiting healthcare worker would. For ambulatory and home care management of MDRO colonization specifically, CDC notes the risk of transmission is less well defined than in acute care, and that consistent standard precautions may suffice — though more evidence is needed.

Who Owns This Decision

The determination of which precaution category applies to a given patient, and when it can be safely discontinued, is typically made or overseen by the facility’s infection preventionist in coordination with the treating clinician — see our Infection Preventionist guide for that role’s scope and certification. A construction or renovation project affecting isolation capacity separately triggers an Infection Control Risk Assessment (ICRA), which is a related but distinct process from day-to-day precaution assignment.

Frequently Asked Questions

What is the difference between droplet precautions and airborne precautions?

Droplet precautions address pathogens spread through close respiratory or mucous-membrane contact that do not remain infectious over long distances — a surgical mask and 3 feet of spatial separation are sufficient, and special air handling is not required. Airborne precautions address pathogens that remain infectious over long distances when suspended in air (measles, chickenpox, tuberculosis) and require a fit-tested N95 or higher respirator plus, where possible, a negative-pressure airborne infection isolation room.

Do transmission-based precautions replace standard precautions?

No. They are always applied in addition to standard precautions — hand hygiene, routine PPE use based on anticipated exposure, and safe injection and equipment-handling practices continue regardless of which transmission-based category, if any, also applies.

Can a patient be on more than one type of precaution at the same time?

Yes. Some infections have more than one transmission route, and CDC’s guideline describes using Contact, Droplet, and Airborne precautions in combination when the evidence supports more than one route — the PPE and placement requirements of each category apply together in that case.

How is the type of precaution decided before a diagnosis is confirmed?

CDC’s guideline provides for empiric use of transmission-based precautions based on clinical syndrome or presentation, applied at the time of presentation rather than waiting for laboratory confirmation, using a reference table of syndromes and conditions that facilities are expected to adapt to local conditions.

Is there a fixed number of days for isolation precautions?

No single fixed duration applies across all infections. Duration is disease-specific and tied to known shedding patterns, treatment response, and — for some organisms — culture or antigen-test confirmation of eradication; consult the guideline’s infection-specific reference table (Appendix A) or your facility’s infection prevention program for a given diagnosis.